Radiation Therapy

Use of pembrolizumab with neoadjuvant chemotherapy and as monotherapy in the adjuvant setting extended OS for patients with early-stage triple-negative breast cancer, according to results from the randomized phase 3 KEYNOTE-522 trial.

The addition of pembrolizumab to adjuvant chemotherapy improved DFS for certain women with newly diagnosed high-risk endometrial cancer, according to randomized phase 3 study results presented at ESMO Congress.

A first-in-human clinical trial will assess the safety of a personalized vaccine to treat diffuse hemispheric glioma, an aggressive brain tumor.

The DecisionDx-SCC test successfully identified which patients with cutaneous squamous cell carcinoma would most likely benefit from adjuvant radiation therapy, according to a study.

Dental extractions after radiation therapy to the head and neck should not be routinely performed due to considerable risk, according to results of a prospective cohort study.

The addition of comprehensive metastasis-directed radiation therapy to chemotherapy improved outcomes for patients with oligometastatic pancreatic ductal adenocarcinoma, according to results of a randomized phase 2 basket trial.

The American Society for Radiation Oncology has issued an updated clinical guideline that outlines best practices for addressing symptomatic bone metastases and improving quality of life for these patients.

Underweight childhood cancer survivors are at an increased risk for late mortality, according to data from a retrospective cohort study published in Pediatric Blood & Cancer.

Acupuncture significantly reduced hot flashes and improved quality of life in women receiving endocrine therapy for breast cancer in three parallel randomized trials, according to results published in Cancer.

Vivek S. Kavadi, MD, MBA, FASTRO, has been named the new CEO for the American Society for Radiation Oncology.